RYBELSUS® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus:1

  • as monotherapy when metformin is considered inappropriate due to intolerance or contraindications;
  • in combination with other medicinal products for the treatment of diabetes (see clinical trials in the Product Monograph for patient populations and drug combinations tested).

 

The first and only oral GLP-1 RA
The first and only oral GLP-1 RA

Novo Nordisk would like every healthcare practitioner to be able to obtain information as easily and quickly as possible. If you need information about RYBELSUS®, please contact: